Breaking News Instant updates and real-time market news.

SESN

Sesen Bio

$1.62

-0.03 (-1.82%)

16:02
08/07/18
08/07
16:02
08/07/18
16:02

Sesen Bio names Thomas Cannell as CEO

Sesen Bio announced key leadership transitions as part of its evolution into a commercial-stage oncology company. Thomas Cannell, DVM has been appointed chief executive officer and a member of the board of directors, bringing with him a wealth of leadership experience in building and overseeing strategic operations and global pharmaceutical commercialization for life science companies. Stephen Hurly left his employment with Sesen Bio effective August 7, 2018. Thomas Cannell most recently served as chief operating officer and president of global commercial products at Orexigen Therapeutics, Inc., where he led the successful commercialization and profitability of Contrave(R). Prior to Orexigen, Dr. Cannell spent 27 years with Merck & Co., Inc., where he held senior leadership positions in global commercialization, consumer marketing, and sales operations and management for both development-stage programs and approved marketed products. While with Merck, he served as president of Merck Canada and head of marketing and strategy for Merck Sharp & Dohme Corp., Japan, a subsidiary of Merck & Co., where he was responsible for setting up a long-standing strategic process and plan, managed a multi-billion-dollar product portfolio and oversaw thousands of employees. In addition, he designed and successfully piloted an innovative, customer-centric commercial model for Merck's U.S. business. Dr. Cannell received his DVM degree from Washington State University.

SESN Sesen Bio
$1.62

-0.03 (-1.82%)

05/22/18
HCWC
05/22/18
NO CHANGE
Target $3.5
HCWC
Buy
Sesen Bio price target raised to $3.50 from $2 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth raised his price target for Sesen Bio to $3.50 saying the topline results from the ongoing Phase 3 Vista study of Vicinium bode well for a positive study. While 81% of treated patients reported adverse events, only 13% of patients reported serious adverse events and only 4% of patients reported adverse events that were believed to be treatment-related, Ramakanth tells investors in a research note. He believes the reported three month safety and efficacy results are well in-line with what Vicinium achieved in the previous Phase 2 study. The analyst expects Vicinium to reach the market by the end of 2019 and generate risk-adjusted revenues of $210M per year by 2030. Ramakanth keeps a Buy rating on Sesen Bio.
07/09/18
ADAM
07/09/18
INITIATION
Target $5
ADAM
Buy
Sesen Bio initiated with a Buy at Canaccord
Canaccord analyst John Newman initiated Sesen Bio with a Buy rating and $5 price target, stating that he models $317M in U.S. peak sales by 2025 for its lead asset, Vicinium, assuming FDA approval in 2020.
07/23/18
JEFF
07/23/18
INITIATION
Target $4
JEFF
Buy
Sesen Bio initiated with a Buy at Jefferies
Jefferies analyst Matthew Andrews started Sesen Bio with a Buy rating and $4 price target. The analyst sees share upside through 2019 driven by 12-month complete response data and FDA agreeing to accelerated approval for Vicinium.

TODAY'S FREE FLY STORIES

FLR

Fluor

$41.39

-2.26 (-5.18%)

16:20
11/20/18
11/20
16:20
11/20/18
16:20
Hot Stocks
Fluor selected for lithium, boron mine project in Nevada »

Fluor Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

TGT

Target

$69.05

-8.08 (-10.48%)

, BBY

Best Buy

$63.54

1.35 (2.17%)

16:20
11/20/18
11/20
16:20
11/20/18
16:20
OnTheFly
Fly Intel: Wall Street's top stories for Tuesday »

Stocks began the session…

TGT

Target

$69.05

-8.08 (-10.48%)

BBY

Best Buy

$63.54

1.35 (2.17%)

CPB

Campbell Soup

$40.57

2.1 (5.46%)

KLIC

Kulicke & Soffa

$21.25

1.345 (6.76%)

A

Agilent

$67.61

5.04 (8.06%)

LIVN

LivaNova

$98.00

-22.28 (-18.52%)

LB

L Brands

$28.43

-6.105 (-17.68%)

AAPL

Apple

$177.10

-8.7 (-4.68%)

BSX

Boston Scientific

$34.05

-1.24 (-3.51%)

NAVI

Navient

$10.74

-1.255 (-10.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 27

    Nov

  • 29

    Nov

  • 04

    Dec

  • 05

    Dec

  • 11

    Dec

  • 03

    Mar

USAT

USA Technologies

$4.96

-0.055 (-1.10%)

16:20
11/20/18
11/20
16:20
11/20/18
16:20
Hot Stocks
USA Technologies provides update on Nasdaq notification of deficiency »

USA Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
11/20/18
11/20
16:20
11/20/18
16:20
Options
Closing CBOE SPX and VIX Index summary for November 20th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMK

GenMark

$5.01

(0.00%)

16:19
11/20/18
11/20
16:19
11/20/18
16:19
Syndicate
Breaking Syndicate news story on GenMark »

GenMark files $150M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 30

    Nov

CAL

Caleres

$30.93

-1.165 (-3.63%)

16:18
11/20/18
11/20
16:18
11/20/18
16:18
Earnings
Caleres reports Q3 adj. EPS 81c, consensus 88c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

RMBL

RumbleON

$5.76

-0.35 (-5.73%)

16:18
11/20/18
11/20
16:18
11/20/18
16:18
Syndicate
Breaking Syndicate news story on RumbleON »

RumbleON files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 10

    Dec

GPS

Gap

$24.65

-0.79 (-3.11%)

16:18
11/20/18
11/20
16:18
11/20/18
16:18
Earnings
Gap narrows FY18 EPS view to $2.55-$2.60 from $2.55-$2.70, consensus $2.56 »

Backs FY18 SSS view of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

MRCY

Mercury Systems

$46.80

-0.48 (-1.02%)

16:18
11/20/18
11/20
16:18
11/20/18
16:18
Hot Stocks
Mercury Systems gets $6.7M Integrated subsystems order for naval electronics »

Mercury Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRI

Thomson Reuters

$47.83

-0.59 (-1.22%)

16:17
11/20/18
11/20
16:17
11/20/18
16:17
Hot Stocks
Thomson Reuters receives court approval for return of capital transaction »

Thomson Reuters announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

STRM

Streamline Health

$0.90

(0.00%)

, WFC

Wells Fargo

$52.54

-0.77 (-1.44%)

16:17
11/20/18
11/20
16:17
11/20/18
16:17
Hot Stocks
Streamline Health extends banking agreement with Wells Fargo into 2020 »

Streamline Health…

STRM

Streamline Health

$0.90

(0.00%)

WFC

Wells Fargo

$52.54

-0.77 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
11/20/18
11/20
16:17
11/20/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$24.65

-0.79 (-3.11%)

16:16
11/20/18
11/20
16:16
11/20/18
16:16
Earnings
Gap reports Q3 EPS 69c, consensus 68c »

Reports Q3 revenue $4.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
11/20/18
11/20
16:16
11/20/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.10

-2.69 (-5.51%)

16:14
11/20/18
11/20
16:14
11/20/18
16:14
Hot Stocks
Breaking Hot Stocks news story on Foot Locker »

Foot Locker up 11% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BJ

BJ's Wholesale

$19.85

-0.22 (-1.10%)

16:13
11/20/18
11/20
16:13
11/20/18
16:13
Hot Stocks
Breaking Hot Stocks news story on BJ's Wholesale »

BJ's Wholesale now…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FL

Foot Locker

$46.05

-2.74 (-5.62%)

16:13
11/20/18
11/20
16:13
11/20/18
16:13
Hot Stocks
Foot Locker CFO says 'encouraged' by Q3 SSS growth »

"We're…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

HTBX

Heat Biologics

$2.04

0.14 (7.37%)

16:13
11/20/18
11/20
16:13
11/20/18
16:13
Syndicate
Heat Biologics fiels to sell common stock and warrants, no amount given »

A.G.P./Alliance Global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.14

-2.65 (-5.43%)

16:13
11/20/18
11/20
16:13
11/20/18
16:13
Hot Stocks
Foot Locker reports merchandise inventories $1.305B at November 3 »

As of November 3, 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

TWI

Titan International

$6.51

-0.4 (-5.79%)

16:13
11/20/18
11/20
16:13
11/20/18
16:13
Hot Stocks
Titan International receives settlement put option notice »

Titan International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$33.93

-0.69 (-1.99%)

16:12
11/20/18
11/20
16:12
11/20/18
16:12
Hot Stocks
Mylan announces voluntary recall of select lots of Valsartan-containing products »

Mylan announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 04

    Dec

BJ

BJ's Wholesale

$19.83

-0.24 (-1.20%)

16:12
11/20/18
11/20
16:12
11/20/18
16:12
Earnings
BJ's Wholesale raises FY18 adj. EPS view to $1.22-$1.26 from $1.17-$1.24 »

Consensus $1.23. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

PLG

Platinum Group

$0.16

-0.0116 (-6.64%)

16:12
11/20/18
11/20
16:12
11/20/18
16:12
Hot Stocks
Platinum Group announces reverse 10:1 stock split »

Platinum Group Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LFC

China Life Insurance

$10.44

-0.21 (-1.97%)

16:12
11/20/18
11/20
16:12
11/20/18
16:12
Upgrade
China Life Insurance rating change  »

China Life Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$69.11

-8.02 (-10.40%)

16:11
11/20/18
11/20
16:11
11/20/18
16:11
Recommendations
Target analyst commentary  »

Target shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.